In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom anthracycline-containing first- or second-line chemotherapy failed received combination paclitaxel
Bruno Cortes Aragão, MD
Advertisement
Articles by Bruno Cortes Aragão, MD
Advertisement
Latest Updated Articles
- Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer
Published: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
2
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
3
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
4
Addressing Early Talquetamab Toxicity Concerns
5
